Compound Evidence File
#EC-2026-0156
Retatrutide 30mg Pen Kit
Filed under Peptides. The bureau holds 216 laboratory returns for this compound from 91 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
91 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 10.0 | 10.0 | 5 Feb 2026 | 27 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 10.0 | 9.9 | 10.0 | 9 May 2026 | 18 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 10.0 | 9.9 | 10.0 | 20 Mar 2026 | 8 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 9.9 | 10.0 | 20 Dec 2025 | 21 Apr 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 10.0 | 10.0 | 23 Dec 2025 | 24 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 10.0 | 9.9 | 10.0 | 17 May 2026 | 24 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 10.0 | 9.9 | 10.0 | 11 May 2026 | 25 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 10.0 | 10.0 | 10.0 | 24 Jan 2026 | 8 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 9.9 | 10.0 | 8 Feb 2026 | 1 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 9.9 | 10.0 | 5 Jun 2026 | 25 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 10.0 | 10.0 | 10.0 | 21 Mar 2026 | 21 May 2026 |
| Paradigm PeptideCASE #VI-2026-0759 | X | 1 | 10.0 | 10.0 | 10.0 | 6 May 2025 | 6 May 2025 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 1 | 10.0 | 10.0 | 10.0 | 20 Jun 2025 | 20 Jun 2025 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 1 | 10.0 | 10.0 | 10.0 | 14 Jan 2025 | 14 Jan 2025 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 9.9 | 9.9 | 10.0 | 19 Feb 2026 | 5 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 9.9 | 9.9 | 10.0 | 17 Jan 2026 | 13 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 1 Jan 2026 | 16 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 9.9 | 9.9 | 9.9 | 8 Jun 2026 | 4 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 9.9 | 9.9 | 9.9 | 8 Jul 2026 | 16 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 9.9 | 9.9 | 10.0 | 19 May 2026 | 17 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 9.9 | 9.9 | 10.0 | 4 Dec 2025 | 4 Apr 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 10.0 | 20 Jul 2026 | 26 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 9.9 | 9.9 | 10.0 | 7 Jul 2026 | 18 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 10.0 | 7 Mar 2026 | 28 May 2026 |
| PeptiAtlasCASE #VI-2026-0739 | X | 1 | 9.1 | 9.1 | 9.1 | 2 Apr 2025 | 2 Apr 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 3 | 9.0 | 8.5 | 10.0 | 21 May 2026 | 21 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 8.8 | 7.8 | 10.0 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 8.6 | 7.5 | 9.9 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 8.5 | 7.6 | 9.6 | 24 May 2026 | 24 May 2026 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 6 | 8.5 | 7.1 | 9.6 | 20 Jun 2025 | 25 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 8.3 | 6.4 | 9.8 | 25 May 2026 | 25 May 2026 |
| UtherCASE #VI-2026-0902 | X | 3 | 8.3 | 7.2 | 9.8 | 9 Jun 2025 | 21 May 2026 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 8.3 | 8.3 | 8.3 | 3 Jul 2025 | 3 Jul 2025 |
| HealthTide BiotechCASE #VI-2026-0955 | X | 1 | 8.0 | 8.0 | 8.0 | 9 Jun 2025 | 9 Jun 2025 |
| Huayi BiotechnologyCASE #VI-2026-0243 | X | 1 | 7.9 | 7.9 | 7.9 | 24 Apr 2025 | 24 Apr 2025 |
| Allen Biotechnology Co ABCCASE #VI-2026-0709 | X | 1 | 7.9 | 7.9 | 7.9 | 2 Apr 2025 | 2 Apr 2025 |
| Skye PeptidesCASE #VI-2026-0451 | X | 2 | 7.8 | 5.9 | 9.7 | 11 Jun 2025 | 24 May 2026 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 7.8 | 7.8 | 7.8 | 24 Apr 2025 | 24 Apr 2025 |
| YimeiCASE #VI-2026-0081 | X | 5 | 7.7 | 6.8 | 8.2 | 3 Jul 2025 | 19 Jan 2026 |
| Peptide PartnersCASE #VI-2026-0295 | X | 3 | 7.7 | 7.3 | 8.3 | 13 Jun 2025 | 21 May 2026 |
| PurePEPSCASE #VI-2026-0552 | X | 1 | 7.7 | 7.7 | 7.7 | 17 Dec 2024 | 17 Dec 2024 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | X | 1 | 7.7 | 7.7 | 7.7 | 14 Jan 2025 | 14 Jan 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 2 | 7.6 | 7.5 | 7.7 | 13 Jun 2025 | 20 May 2026 |
| Astro PeptidesCASE #VI-2026-0424 | X | 2 | 7.6 | 7.0 | 8.2 | 13 Jun 2025 | 23 May 2026 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 7.6 | 7.6 | 7.6 | 9 Jun 2025 | 9 Jun 2025 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 7.6 | 7.6 | 7.6 | 14 Jan 2025 | 14 Jan 2025 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | X | 2 | 7.4 | 6.4 | 8.3 | 14 Jan 2025 | 25 May 2026 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 7.4 | 7.4 | 7.4 | 13 Jun 2025 | 13 Jun 2025 |
| AKS ChemCASE #VI-2026-0313 | X | 1 | 7.4 | 7.4 | 7.4 | 16 Mar 2025 | 16 Mar 2025 |
| YB PeptideCASE #VI-2026-0813 | X | 1 | 7.3 | 7.3 | 7.3 | 2 Jul 2025 | 2 Jul 2025 |
| Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 | X | 5 | 6.9 | 5.8 | 8.7 | 20 Jun 2025 | 21 May 2026 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | X | 4 | 6.9 | 4.7 | 10.0 | 7 May 2025 | 23 May 2026 |
| Planet PeptideCASE #VI-2026-0092 | X | 3 | 6.9 | 6.1 | 7.9 | 3 Jun 2025 | 23 May 2026 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 6.8 | 6.8 | 6.8 | 7 May 2025 | 7 May 2025 |
| Pura PeptidesCASE #VI-2026-0307 | X | 1 | 6.5 | 6.5 | 6.5 | 13 Feb 2025 | 13 Feb 2025 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 6.4 | 6.4 | 6.4 | 28 Mar 2025 | 28 Mar 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 1 | 6.3 | 6.3 | 6.3 | 6 May 2025 | 6 May 2025 |
| Zztai PeptideCASE #VI-2026-0192 | C | 2 | 6.1 | 5.3 | 6.9 | 14 Jan 2025 | 25 May 2026 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 6.1 | 6.1 | 6.1 | 25 Apr 2025 | 25 Apr 2025 |
| BeiBangAnCASE #VI-2026-0899 | X | 3 | 6.0 | 5.4 | 6.4 | 21 May 2025 | 21 May 2026 |
| OupeptideCASE #VI-2026-0435 | X | 5 | 5.8 | 4.4 | 7.6 | 2 Jul 2025 | 23 May 2026 |
| Peptide GurusCASE #VI-2026-0854 | X | 1 | 5.6 | 5.6 | 5.6 | 8 Jul 2025 | 8 Jul 2025 |
| TCICASE #VI-2026-0650 | X | 1 | 5.6 | 5.6 | 5.6 | 13 Feb 2025 | 13 Feb 2025 |
| HazelCASE #VI-2026-0392 | X | 1 | 5.6 | 5.6 | 5.6 | 9 Jun 2025 | 9 Jun 2025 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | X | 1 | 5.5 | 5.5 | 5.5 | 17 Dec 2024 | 17 Dec 2024 |
| LSPLCASE #VI-2026-0523 | X | 1 | 5.4 | 5.4 | 5.4 | 9 Jun 2025 | 9 Jun 2025 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 5.4 | 5.4 | 5.4 | 27 Feb 2025 | 27 Feb 2025 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 5.3 | 5.3 | 5.3 | 3 Jun 2025 | 3 Jun 2025 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 5.3 | 5.3 | 5.3 | 17 Dec 2024 | 17 Dec 2024 |
| TydesCASE #VI-2026-0493 | X | 4 | 5.2 | 3.6 | 6.6 | 17 Dec 2024 | 19 Jan 2026 |
| PurePeptidesCASE #VI-2026-0234 | X | 1 | 5.2 | 5.2 | 5.2 | 27 Feb 2025 | 27 Feb 2025 |
| Accelerate LabsCASE #VI-2026-0686 | X | 2 | 5.0 | 3.5 | 6.6 | 25 Apr 2025 | 25 May 2026 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 5.0 | 5.0 | 5.0 | 2 Jul 2025 | 2 Jul 2025 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 2 | 4.9 | 3.8 | 6.1 | 14 Jan 2025 | 25 May 2026 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 4.9 | 4.9 | 4.9 | 9 Jun 2025 | 9 Jun 2025 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | E | 4 | 4.8 | 3.1 | 6.8 | 2 Apr 2025 | 23 May 2026 |
| ScienceCASE #VI-2026-0636 | X | 1 | 4.6 | 4.6 | 4.6 | 16 Mar 2025 | 16 Mar 2025 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 4.4 | 4.4 | 4.4 | 27 Feb 2025 | 27 Feb 2025 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 4.2 | 4.2 | 4.2 | 11 Jun 2025 | 11 Jun 2025 |
| DeuschemCASE #VI-2026-0004 | X | 1 | 4.0 | 4.0 | 4.0 | 25 Apr 2025 | 25 Apr 2025 |
| Coastal PeptidesCASE #VI-2026-0958 | X | 2 | 3.8 | 3.4 | 4.1 | 17 Dec 2024 | 24 May 2026 |
| Peptides For SaleCASE #VI-2026-0614 | X | 1 | 2.9 | 2.9 | 2.9 | 6 May 2025 | 6 May 2025 |
| Forever Young PharmacyCASE #VI-2026-0654 | X | 1 | 2.2 | 2.2 | 2.2 | 3 Jun 2025 | 3 Jun 2025 |
| HK Fat CatCASE #VI-2026-0376 | X | 1 | 0.9 | 0.9 | 0.9 | 9 Jun 2025 | 9 Jun 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.7 | 0.7 | 0.7 | 2 Apr 2025 | 2 Apr 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 0.0 | 0.0 | 0.0 | 25 Apr 2025 | 25 Apr 2025 |
| Peptide ArkCASE #VI-2026-0350 | X | 1 | 0.0 | 0.0 | 0.0 | 17 Dec 2024 | 17 Dec 2024 |
| Marvel PeptideCASE #VI-2026-0507 | X | 1 | 0.0 | 0.0 | 0.0 | 27 Feb 2025 | 27 Feb 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 0.0 | 0.0 | 0.0 | 11 Jun 2025 | 11 Jun 2025 |
Open any subject to view the batch-level evidence for Retatrutide 30mg Pen Kit alone.